Other languages Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 15:59:51 01/05/2024 BST			5-day change	1st Jan Change
1,966 ^DKK	+0.46%		-2.12%	-8.79%

04-30	Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	MT
04-30	Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment	MT

Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment	04-30
Pfizer Inc. and Genmab A/S Announce FDA Grants Full Approval for TIVDAK to Treat Recurrent or Metastatic Cervical Cancer	04-29
AVIS D'ANALYSTES DU JOUR : BNP Paribas, Renault, Pernod-Ricard, Eurofins, Ferrari, Worldline, Sika, Elior...	04-04
OPINIONES DE LOS ANALISTAS DEL DÍA : Adyen, Burberry, Endesa, Ferrari, Genmab, Melia Hotels, Telefónica, Sika..	04-04
Genmab : l'acquisition de ProfoundBio accueillie sans émotion	04-03
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	04-03
Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio	04-03
Denmark's Genmab to acquire ProfoundBio for $1.8 billion	04-03
Bolsa de Madrid: Después de Semana Santa, algo va mal	04-03
Genmab to Acquire ProfoundBio for $1.8 Billion	04-03
Après Pâques, un truc qui cloche	04-03
En Direct des Marchés : Thales, Renault, Eurofins, Virbac, Atos, Clariant, Sika, Genmab...	04-03
Genmab to Purchase US-based ProfoundBio for $1.8 Billion	04-03
Genmab neemt ProfoundBio over	04-03
EN DIRECTO DESDE LOS MERCADOS: Repsol, Naturgy, Siemens, Intel, General Motors, Sika, Xiaomi, Kering...	04-03
Genmab A/S commences an Equity Buyback Plan under the authorization approved on March 13, 2024.	03-25
Genmab Completes Share Buyback Program	03-18
Genmab to Repurchase Up to $511 Million Shares	03-15
Genmab A/S Announces Executive Changes	03-13
Genmab Seeks M&A Opportunities	03-13

No results for this search

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 11:10 am